# Architects of the Developing Brain: Cytoskeleton-Organizing Molecules in Neurodevelopmental Disorders

**Authors:** Ksenia A. Achkasova, Pavel V. Subbotin, Vadim V. Zhukov, Anastasia E. Filat’eva, Victor S. Tarabykin, Elena V. Kondakova

PMC · DOI: 10.3390/cells15060537 · Cells · 2026-03-17

## TL;DR

This review explores how cytoskeleton molecules shape brain development and contribute to neurodevelopmental disorders.

## Contribution

The paper provides a comprehensive overview of cytoskeletal roles in cortical development and their disruption in neurodevelopmental disorders.

## Key findings

- Cytoskeleton components regulate key processes like neuronal migration and synaptogenesis.
- Genetic mutations in cytoskeletal proteins are linked to disorders such as microcephaly and lissencephaly.
- Cytoskeletal dysfunction leads to altered cellular behavior and specific clinical phenotypes.

## Abstract

Different components of the cytoskeleton are very important determinants of brain development. They orchestrate multiple cellular processes involved in all phases of cerebral cortex development. In this review, we summarize current knowledge on the components of the cytoskeleton—microtubules, actin filaments, and intermediate filaments—and their roles in cortical development. We provide a detailed analysis of how cytoskeleton molecules control neuronal progenitor proliferation, neuronal migration, polarization, axon and dendrite specification and outgrowth, and synaptogenesis. We further examine how pathogenic variants in genes encoding cytoskeletal proteins or their regulators disrupt particular steps of neurogenesis and contribute to major neurodevelopmental disorders (NDDs). Focusing on NDDs such as microcephaly, lissencephaly, corpus callosum agenesis, and synaptopathies, we discuss consequences of cytoskeletal dysfunctions causing altered cellular behavior and clinical phenotypes. By linking molecular defects to developmental and phenotypic consequences, this review highlights the cytoskeleton as a central element in neurodevelopmental pathologies and underscores its potential as a target for future therapeutic strategies.

## Linked entities

- **Diseases:** microcephaly (MONDO:0001149), lissencephaly (MONDO:0018838), corpus callosum agenesis (MONDO:0009022)

## Full-text entities

- **Genes:** RAC3 (Rac family small GTPase 3) [NCBI Gene 5881], MAP4 (microtubule associated protein 4) [NCBI Gene 4134], KNL1 (kinetochore scaffold 1) [NCBI Gene 57082] {aka AF15Q14, CASC5, CT29, D40, MCPH4, PPP1R55}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, RMDN1 (regulator of microtubule dynamics 1) [NCBI Gene 51115] {aka CGI-90, FAM82B, RMD-1, RMD1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, RELN (reelin) [NCBI Gene 5649] {aka ETL7, LIS2, PRO1598, RL}, Ophn1 (oligophrenin 1) [NCBI Gene 94190] {aka C130037N19Rik, Wtgr}, INA (internexin neuronal intermediate filament protein alpha) [NCBI Gene 9118] {aka NEF5, NF-66, NF66, TXBP-1}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, Fmn2 (formin 2) [NCBI Gene 54418], TUBG1 (tubulin gamma 1) [NCBI Gene 7283] {aka CDCBM4, GCP-1, TUBG, TUBGCP1}, TIAM1 (TIAM Rac1 associated GEF 1) [NCBI Gene 7074] {aka NEDLDS, TIAM-1}, MYH14 (myosin heavy chain 14) [NCBI Gene 79784] {aka DFNA4, DFNA4A, FP17425, MHC16, MYH17, NMHC II-C}, ENAH (ENAH actin regulator) [NCBI Gene 55740] {aka ENA, MENA, NDPP1}, CTTN (cortactin) [NCBI Gene 2017] {aka EMS1}, CDC42 (cell division cycle 42) [NCBI Gene 998] {aka CDC42Hs, G25K, TKS}, VIM (vimentin) [NCBI Gene 7431], MARK1 (microtubule affinity regulating kinase 1) [NCBI Gene 4139] {aka MARK, Par-1c, Par1c}, TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901] {aka BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX}, NDC80 (NDC80 kinetochore complex component) [NCBI Gene 10403] {aka HEC, HEC1, HsHec1, KNTC2, TID3, hsNDC80}, RHOB (ras homolog family member B) [NCBI Gene 388] {aka ARH6, ARHB, MST081, MSTP081, RHOH6}, MAPRE1 (microtubule associated protein RP/EB family member 1) [NCBI Gene 22919] {aka EB1}, Slc17a7 (solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7) [NCBI Gene 72961] {aka 2900052E22Rik, Vglut1}, NEFM (neurofilament medium chain) [NCBI Gene 4741] {aka NEF3, NF-M, NFM}, CDH2 (cadherin 2) [NCBI Gene 1000] {aka ACOGS, ADHD8, ARVD14, CD325, CDHN, CDw325}, Cttnbp2 (cortactin binding protein 2) [NCBI Gene 30785] {aka 3010022N24Rik, 4732477G22Rik, 6430526E05, 9130022E09Rik, Cortbp2, ORF4}, CFL2 (cofilin 2) [NCBI Gene 1073] {aka NEM7}, MAPK8IP1 (mitogen-activated protein kinase 8 interacting protein 1) [NCBI Gene 9479] {aka IB1, JIP-1, JIP1, PRKM8IP}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, PRUNE1 (prune exopolyphosphatase 1) [NCBI Gene 58497] {aka DRES-17, DRES17, H-PRUNE, HTCD37, NMIHBA, PRUNE}, CDK5RAP2 (CDK5 regulatory subunit associated protein 2) [NCBI Gene 55755] {aka C48, Cep215, MCPH3}, Pfn1 (profilin 1) [NCBI Gene 18643] {aka Pfn}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, CFL1 (cofilin 1) [NCBI Gene 1072] {aka CFL, HEL-S-15, cofilin}, TUBB2B (tubulin beta 2B class IIb) [NCBI Gene 347733] {aka CDCBM7, PMGYSA, bA506K6.1}, TUBB (tubulin beta class I) [NCBI Gene 203068] {aka CDCBM6, CSCSC1, M40, OK/SW-cl.56, TUBB1, TUBB5}, ARHGEF2 (Rho/Rac guanine nucleotide exchange factor 2) [NCBI Gene 9181] {aka GEF, GEF-H1, GEFH1, LFP40, Lfc, NEDMHM}, DAB1 (DAB adaptor protein 1) [NCBI Gene 1600] {aka SCA37}, Reln (reelin) [NCBI Gene 19699] {aka reeler, rl}, Gap43 (growth associated protein 43) [NCBI Gene 14432] {aka B-50, Basp2, GAP-43}, LRP8 (LDL receptor related protein 8) [NCBI Gene 7804] {aka APOER2, HSZ75190, LRP-8, MCI1}, AGFG1 (ArfGAP with FG repeats 1) [NCBI Gene 3267] {aka HRB, RAB, RIP}, Pafah1b1 (platelet-activating factor acetylhydrolase, isoform 1b, subunit 1) [NCBI Gene 18472] {aka LIS-1, Lis1, MMS10-U, Mdsh, Ms10u, Pafaha}, DPYSL5 (dihydropyrimidinase like 5) [NCBI Gene 56896] {aka CRAM, CRMP-5, CRMP5, CV2, RTSC4, Ulip6}, MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}, Map6 (microtubule-associated protein 6) [NCBI Gene 17760] {aka 2810411E12Rik, Map-6, Mtap6, STOP}, TUBB2A (tubulin beta 2A class IIa) [NCBI Gene 7280] {aka CDCBM5, TUBB, TUBB2}, FYN (FYN proto-oncogene, Src family tyrosine kinase) [NCBI Gene 2534] {aka SLK, SYN, p59-FYN}, MTSS2 (MTSS I-BAR domain containing 2) [NCBI Gene 92154] {aka ABBA, ABBA-1, ABBA1, IDDOF, MTSS1L}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, IMMT (inner membrane mitochondrial protein) [NCBI Gene 10989] {aka HMP, MICOS60, MINOS2, Mic60, P87, P87/89}, Rho (rhodopsin) [NCBI Gene 212541] {aka Noerg1, Opn2, Ops, RP4}, LIMK1 (LIM domain kinase 1) [NCBI Gene 3984] {aka LIMK, LIMK-1}, DCX (doublecortin) [NCBI Gene 1641] {aka DBCN, DC, LISX, SCLH, XLIS}, CDK5 (cyclin dependent kinase 5) [NCBI Gene 1020] {aka LIS7, PSSALRE}, YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon) [NCBI Gene 7531] {aka 14-3-3E, HEL2, KCIP-1, MDCR, MDS}, FMN2 (formin 2) [NCBI Gene 56776], NEFL (neurofilament light chain) [NCBI Gene 4747] {aka CMT1F, CMT2E, CMTDIG, NF-L, NF68, NFL}, RHOC (ras homolog family member C) [NCBI Gene 389] {aka ARH9, ARHC, H9, RHOH9}
- **Diseases:** LTD (MESH:D000088562), ASD (MESH:D001321), enlarged ventricles (MESH:D006332), Seizures Short stature (MESH:D004827), cytoskeletal dysfunction (MESH:D006331), neonatal death (MESH:D066087), structural abnormalities (MESH:C566527), Lissencephaly (MESH:D054082), hypoplasia (MESH:D000080344), impaired social learning and sensory processing (MESH:D007859), depression (MESH:D003866), hypotension (MESH:D007022), migration disorders (MESH:D054081), AFs (MESH:C579880), facial dysmorphism (MESH:C565579), schizophrenia (MESH:D012559), lissos":smooth (MESH:D018235), injury to (MESH:D014947), polymicrogyria (MESH:D065706), NDDs (MESH:D002658), BRWS (OMIM:243310), hippocampal malformations (MESH:D000092223), impaired (MESH:D060825), Miller-Dieker syndrome (MESH:D054221), tubulopathies (MESH:C557674), Deficiencies (MESH:D007153), congenital (MESH:D008209), CNS defects (MESH:D002494), hyperactivity (MESH:D006948), striatal heterotopia (MESH:C537500), colpocephaly (MESH:C535973), commissural dysgenesis (MESH:C537048), cognitive and behavioral abnormalities (OMIM:614756), brain malformations (MESH:D020785), intellectual disabilities (MESH:D008607), hypertelorism (MESH:D006972), cognitive impairments (MESH:D003072), cortical abnormalities (MESH:D054220), cerebellar hypoplasia (MESH:C562568), autosomal recessive primary microcephaly (MESH:C579935), Microcephaly (MESH:D008831), congenital ptosis (MESH:C564553), cerebral palsy (MESH:D002547), migration (MESH:D014085), micro- and macrocephaly (MESH:C536681), brain abnormalities (MESH:D001927), striate heterotopia (MESH:C536162), cobblestone lissencephaly (MESH:D054222), delay (MESH:D006968), cytoskeleton disorders (MESH:D009358), heterotopia (MESH:D054091), ASDs (MESH:D000067877), glioma (MESH:D005910), agenesis (MESH:C536482), Mowat-Wilson syndrome (MESH:C536990), anxiety (MESH:D001007), Seckel syndrome type 7 (MESH:C537533), motor impairments (MESH:D000068079), hearing loss (MESH:D034381), cytoskeletal defects (MESH:D000013)
- **Chemicals:** Taxol (MESH:D017239), GDP (MESH:D006153), calcium (MESH:D002118), Ca2+ (-), ADP (MESH:D000244), vincristine (MESH:D014750), glutamate (MESH:D018698), nocodazole (MESH:D015739), GTP (MESH:D006160), Colchicine (MESH:D003078), magnesium (MESH:D008274), phosphate (MESH:D010710), alkaloids (MESH:D000470), ATP (MESH:D000255)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** p.Asp30Asn, p.Arg402Cys, S140G, p.His1045Arg, V353I, p.Gly98Arg, c.329delT, p.R66W, p.F28S, p.Asp262Gly, p.Leu387Pro, p.Ser155Phe, c.275A>G, Ser297, p.Arg402His, 28 S, p.Ser1071Pro, M299V, p.Asn1709Ser, p.Tyr1055Cys, p.Gln1222Arg, c.1097dupG, R671W, E401K, p.Arg196His, c.2972G>A, c.1117A>T
- **Cell lines:** C6 — Rattus norvegicus (Rat), Rat malignant glioma, Cancer cell line (CVCL_0194), SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13025994/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13025994/full.md

## References

409 references — full list in the complete paper: https://tomesphere.com/paper/PMC13025994/full.md

---
Source: https://tomesphere.com/paper/PMC13025994